EMIT Imaging is the leading manufacturer of Cryo-Fluorescence Tomography (CFT) systems and provider of CFT fee-for-service research. CFT was created to better visualize drug distribution and protein expression (PK/PD) in whole animals at high resolution and sensitivity. Following developing a prototype system and demonstrating the vast potential of CFT, EMIT Imaging, Inc. was spun out of Invicro, LLC in 2018. EMIT designed and manufactured our flagship product, XerraTM, a fully automated preclinical imaging platform, and launched the first-generation production system in 2019. In 2023, EMIT launched CFT services to the global research community. EMIT developed CFT and Xerra to help researchers discover more from valuable preclinical experiments, complementing existing experimental paradigms and imaging workflows. CFT applications span drug discovery and delivery, oncology and immunotherapy, gene and cell therapy, neuroscience, and beyond. EMIT Imaging is driven to develop innovative CFT applications, systems, and software that meet our customers’ and collaborators’ needs. We are working on feature enhancements, workflow optimization, and data science tools that further the utility and useability of Xerra and CFT. The company is based in Baltimore, MD, and Boston, MA.
Embrient
Irreproducibility… not being able to consistently replicate cell culturing is a BIG problem in nearly all research institutions today. After 4 years of intense work, and leveraging off a $2M Fast-Track NIH grant, Embrient is launching a CO2 continuous flow “Air Veil” incubator that directly attacks the problem. The Air Veil maintains conditions – temperature, Ph, humidity and O2 gas mix – way better than any other incubator on the market today. Stop exposing your cell cultures to so much disruption!
E-BIOT BIOSCIENCE INC.
At e-BLOT, we revolutionized Western blot imaging in 2019 with the launch of the Touch Imager. This innovative chemiluminescence system offers the highest sensitivity and the broadest quantitative range on the market. Our success is built on dedication, expertise, and experience, as we turn challenges and setbacks into opportunities for innovation. Guided by the belief that no challenge is insurmountable, we continuously push the boundaries of imaging technology to meet and exceed our customers’ evolving needs.
DPBIO
DPBIO is a pioneering innovator based in California, specializing in high-throughput droplet microfluidic technology and providing cutting-edge life science solutions to researchers and industry leaders worldwide. At DPBIO, we integrate advanced microfluidic technology with life sciences to develop comprehensive solutions, including microfluidic chips, instruments, and reagents. Our flagship products—such as the CytoSpark® High-throughput Screening System, OMNIdrop System—empower scientists in antibody discovery, enzyme evolution, strain screening, small-molecule drug screening, cancer research, early disease detection, viral quantification, and biopharmaceutical quality control. Trusted by leading biotech and pharmaceutical companies, top-tier research institutions, and clinical laboratories worldwide, DPBIO is committed to advancing life sciences with high-performance analytical and detection systems. Our mission is to accelerate drug discovery, synthetic biology, biomedical research, and precision medicine, driving breakthroughs that transform life science innovation.
DeNovix Inc.
DeNovix Inc. develops, manufactures and sells award-winning laboratory equipment for life science applications. Our stand-alone systems include DS-Series 1 µL UV-Vis Spectrophotometers / Fluorometers and CellDrop™ Automated Cell Counters for cell counting without slides. | DeNovix Inc. (Wilmington, Delaware, USA) develops, manufactures and sells award-winning laboratory equipment for life science applications. Our products include DS-Series 1 µL UV-Vis Spectrophotometers / Fluorometers and CellDrop™ Automated Cell Counters for cell counting without slides. DeNovix designs instrumentation that leads the way in solving the problems of today’s laboratories, improving efficiency, accuracy and sustainability of laboratory workflows. Our stand-alone instruments for quantification of nucleic acids and proteins include UV-Vis Spectrophotometers, Fluorometers and integrated systems combining 1 µL UV-Vis, cuvette UV-Vis and Fluorescence. In the field of cell biology, CellDrop brightfield and fluorescence cell counters include patented DirectPipette™ technology to eliminate plastic slides and reduce laboratory costs.
Curiosis
Curiosis Inc. is dedicated to developing, producing, and supplying innovative systems for cell-based analysis and lab automation. Our advanced solutions are designed to enhance the efficiency, precision, and scalability of cell-based research, helping scientists and medical professionals achieve better outcomes. We strive to establish ourselves as a leader in the bioindustry, focusing on delivering products that meet the evolving needs of both scientific and medical communities. By integrating cutting-edge technologies and fostering continuous innovation, we aim to make significant contributions to the advancement of biomedical research and the improvement of global healthcare outcomes.
CTCELLS
CTCELLS is an innovative cancer diagnostics and drug development company founded on the belief that effective cancer care requires solutions tailored to each individual. Powered by Circulating Tumor Cell (CTC) liquid biopsy, CTCELLS enables automated isolation of diverse CTC subtypes to better capture the full biological heterogeneity of cancer. To translate these insights into actionable research and clinical value, CTCELLS integrates its proprietary Continuous Centrifugal Microfluidics (CCM) technology for robust, automated CTC processing, lossless cell staining enabled by hydrogel-based HypICC to preserve cellular information for downstream analysis, and single-cell picking to support precise molecular profiling and functional characterization. By connecting cancer-specific cellular characteristics with the most suitable therapies, CTCELLS is committed to improving patient outcomes and accelerating the development of next-generation treatments, bringing new hope to patients facing difficult-to-treat cancers. | CTCELLS is an innovative biotechnology company striving for a total solution for cancer. With platform technologies in both therapeutics and diagnostics, the RACE platform is designed to deliver safer and more effective immunotherapies by optimizing the selection and administration of treatment based on a patient’s unique immunological profile. The TRACE Platform, on the other hand, is a cutting-edge liquid biopsy system that captures all types of Circulating Tumor Cells (CTCs). This allows for more precise diagnostics and treatment planning, targeting a range of cancer types. CTCELLS is committed to improving patient outcomes by integrating the latest in scientific research and technology into their products.
CrestOptics Spa
CrestOptics S.p.A. is a leading deep tech company specializing in the development and manufacturing of advanced systems for fluorescence microscopy. We provide high-end, flexible solutions like the X-Light Spinning Disk confocal series and the DeepSIM super-resolution module, enabling researchers in the life science, biotech, and pharma industries to achieve faster, high-quality, and high-resolution imaging for groundbreaking biological discoveries.
Covaris
Covaris, a PerkinElmer Company, is a leader in sample preparation solutions across multiomics research and clinical applications. Powered by proprietary Adaptive Focused Acoustics® (AFA®) technology, our portfolio of advanced instruments, consumables, reagents, and kits for pre-analytical sample preparation deliver exceptional accuracy and reproducibility, enabling researchers to generate higher-quality data, develop novel assays, and drive breakthrough discoveries in life sciences. From academic labs to global biopharma organizations, Covaris is trusted by scientists who demand precision at every step of the analytical workflow. Learn more at www.covaris.com. | Covaris provides comprehensive, integrated workflows for proteomics, genomics, and beyond. Covaris solutions can help you improve your sample preparation performance. They easily integrate into manual or automated workflows and support a wide variety of sample types, batch sizes, and input volumes. By reducing touchpoints, turnaround time, and repeat downstream analysis, Covaris sample prep solutions can lower your total workflow costs. Learn how Covaris can help take you further, faster.
CoolLED Ltd
CoolLED designs and manufactures cutting edge LED Illumination Systems for researchers and clinicians using the latest LED technology. Since our team of four introduced the first commercially available LED Illumination System in 2006, we have led the way in transforming LED microscope lighting for fluorescence microscopy and transmitted illumination. Now we are a fast-growing company based in the UK, with a vast product range and technical expertise spanning optical engineering and the life sciences.